ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ELUTIA INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.82+0.02 (+2.67%)
Close on Oct 19, 2026
- Market cap
- $36.05M
- P/E (TTM)
- 0.9
- Dividend yield
- –
Elutia statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Elutia | Industry median |
|---|---|---|
| Market Cap | $36.10M | $166.30M |
| Enterprise Value | $16.21M | $88.19M |
| PS Ratio | 2.98 | 3.65 |
| PB Ratio | 2.29 | 2.03 |
| P/TBV Ratio | 2.45 | 2.29 |
Enterprise value
| Measure | Elutia | Industry median |
|---|---|---|
| EV / Sales | 1.34 | 2.51 |
Income (trailing twelve months)
| Measure | Elutia | Industry median |
|---|---|---|
| Revenue | $12.14M | $58.34M |
| Gross Profit | $7.02M | $105.94M |
| Operating Income | -$26.07M | -$21.40M |
| Pretax Income | -$22.36M | -$14.34M |
| Net Income | $51.81M | -$22.46M |
| EBITDA | -$24.37M | -$16.91M |
Margins
| Measure | Elutia | Industry median |
|---|---|---|
| Gross Margin | 57.8% | 52.9% |
| Operating Margin | -214.9% | -44.0% |
| Pretax Margin | -184.2% | -13.3% |
| Profit Margin | 426.9% | -40.2% |
| EBITDA Margin | -200.8% | -30.2% |
| FCF Margin | -379.3% | -9.27% |
Returns
| Measure | Elutia | Industry median |
|---|---|---|
| Return on Assets (ROA) | 133.7% | -40.9% |
| Return on Capital Employed (ROCE) | -115.4% | -38.1% |
Growth
| Measure | Elutia | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -0.34% | 5.96% |
| Revenue Growth (3Y CAGR) | -19.8% | 2.25% |
| Revenue Growth (5Y CAGR) | -22.0% | 6.48% |
Balance sheet
| Measure | Elutia | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $19.90M | $61.43M |
| Net Cash (Debt) | $19.90M | $15.35M |
| Net Cash Per Share | $0.45 | $0.66 |
| Equity (Book Value) | $15.75M | $49.09M |
| Book Value Per Share | $0.36 | $1.37 |
| Tangible Book Value | $14.76M | $23.52M |
| Working Capital | $16.17M | $76.81M |
Financial position
| Measure | Elutia | Industry median |
|---|---|---|
| Current Ratio | 1.77 | 3.34 |
| Quick Ratio | 1.01 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Elutia | Industry median |
|---|---|---|
| Operating Cash Flow | -$43.99M | -$12.35M |
| Capital Expenditures | -$2.03M | -$1.08M |
| Free Cash Flow | -$46.03M | -$20.22M |
| FCF Per Share | -$1.04 | -$0.42 |
Efficiency
| Measure | Elutia | Industry median |
|---|---|---|
| Asset Turnover | 0.31 | 0.39 |
| Inventory Turnover | 1.30 | 2.70 |
| Revenue Per Employee | $466.73K | $404.87K |
| Profits Per Employee | $1.99M | -$703.34K |
| Employee Count | 26 | 74 |
Dividends and yields
| Measure | Elutia | Industry median |
|---|---|---|
| Earnings Yield | 143.5% | -23.3% |
| FCF Yield | -127.5% | -8.72% |
Shares
| Measure | Elutia | Industry median |
|---|---|---|
| Shares Outstanding | 44,289,200 | 58,127,000 |
| Shares Change (YoY) | 13.7% | 10.9% |
| Float | 21,244,100 | 49,136,700 |
| Shares Held by Insiders | 52.0% | 11.6% |
| Shares Held by Institutions | 39.8% | 59.4% |
Taxes
| Measure | Elutia | Industry median |
|---|---|---|
| Income Tax | $75.00K | $79.87K |
Scores
| Measure | Elutia | Industry median |
|---|---|---|
| Altman Z-Score | -6.61 | -0.22 |
| Piotroski F-Score | 6 | 4 |
| Beneish M-Score | 4.59 | -2.62 |
Calculated by StockData from Elutia's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.